Articles

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

Gold prices settled Thursday at their highest level in four weeks, defying their usual inverse relationship with strength in the U.S. dollar and gains in Treasury yields, as fiscal worries prompt investors seek out safe-haven assets.

Flutter said this football season has seen the most “customer-friendly” NFL outcomes since the launch of online sports betting.

Making saving easy remains essential

We told you he would months ago, when he made the promise.

Roths may be overrated for most investors, new research suggests.

A top U.K. government official told Parliament he can’t afford a subscription to Bloomberg News.

UBS stock reached a new 16-year high after the Wall Street Journal said the bank is about to get fined hundreds of millions of dollars.

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

An analyst sees big upside ahead, fueled by rapid growth in high-bandwidth memory for AI.

Rising unemployment prodded the Federal Reserve to cut interest rates last fall despite lingering inflation — and the jobless rate could still be the deciding factor for future rate cuts.

The U.S. labor market remains healthy and the Federal Reserve can take a gradual and patient approach to future rate cuts, Boston Fed President Susan Collins said Thursday.